Pauls Matthew Insider Trades & Stock Holdings

Director · Pelthos Therapeutics Inc. · Latest filing Oct 2, 2026

Pauls Matthew, Director at Pelthos Therapeutics Inc. has 1 Form 4 trade on file since Oct 2, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($16.51K), net -$16.51K. Latest filing: disposed of 786 shares of $PTHS on Oct 2, 2026 at $21.

Trades on file

1

Open-market bought

$0

Open-market sold

$16.51K

Net open-market

-$16.51K

Latest filing

Oct 2, 2026

All insider trades by Pauls Matthew

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$PTHS	Sell (Open-market sale) 10b5-1	786	$21	$16.51K						Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Pauls Matthew traded

• $PTHS

Frequently asked questions

Has Pauls Matthew been buying or selling stock?

Pauls Matthew has 0 open-market purchases and 1 open-market sale on file, net -$16.51K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Pauls Matthew's latest insider trade?

disposed of 786 shares of $PTHS on Oct 2, 2026 at $21.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.